The machado-joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability

  • Durcan T
  • Kontogiannea M
  • Thorarinsdottir T
 et al. 
  • 71

    Readers

    Mendeley users who have this article in their library.
  • 71

    Citations

    Citations of this article.

Abstract

Machado-Joseph disease (MJD), the most common dominantly inherited ataxia worldwide, is caused by a polyglutamine (polyQ) expansion in the deubiquitinating (DUB) enzyme ataxin-3. Interestingly, MJD can present clinically with features of Parkinsonism. In this study, we identify parkin, an E3 ubiquitin-ligase responsible for a common familial form of Parkinson's disease, as a novel ataxin-3 binding partner. The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells. Compared with wild-type ataxin-3, MJD-linked polyQ-expanded mutant ataxin-3 is more active, possibly owing to its greater efficiency at DUB K27- and K29-linked Ub conjugates on parkin. Remarkably, mutant but not wild-type ataxin-3 promotes the clearance of parkin via the autophagy pathway. The finding is consistent with the reduction in parkin levels observed in the brains of transgenic mice over-expressing polyQ-expanded but not wild-type ataxin-3, raising the intriguing possibility that increased turnover of parkin may contribute to the pathogenesis of MJD and help explain some of its parkinsonian features.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Thomas M. Durcan

  • Maria Kontogiannea

  • Thorhildur Thorarinsdottir

  • Lara Fallon

  • Aislinn J. Williams

  • Ana Djarmati

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free